Icahn School of Medicine at Mount Sinai Unveils BioMedical Laureates Program to Drive Diversity, Enhance Mentorship
Junior program will launch simultaneously
The Icahn School of Medicine at Mount Sinai today unveiled BioMedical Laureates at Mount Sinai, a program intended to increase diversity among its basic and clinical research faculty and reinforce the school’s strong ethic of mentorship. BioMedical Laureates and a companion program, Junior Laureates, will both launch in January 2021, and will each announce new Laureates annually.
“This program is among the first programs of its kind in the country that is dedicated to the enhancement of diversity among senior research scientists at an academic medical center. The program will significantly add to our existing efforts to diversify our faculty,” says Dennis S. Charney, MD, Anne, and Joel Ehrenkranz Dean, Icahn School of Medicine at Mount Sinai, and President for Academic Affairs, Mount Sinai Health System. “A diverse medical and scientific community will drive innovation, enhance clinical care, and enrich teaching and mentorship, fulfilling the mission that drives our work. Our Laureates will bring with them a breadth of ideas and lived experiences while lending new perspectives and raising new questions, which in turn will lead to lasting systemic change.”
The program will include two components: a biomedical laureates program and a complementary junior program. The Mount Sinai BioMedical Laureate will be selected based on the candidate’s scientific track record and future promise as a leader in academic medicine and will undergo a rigorous review by a committee of senior researchers from across the institution. Selected Laureates will be given a competitive startup package based on scientific and professional development needs, which includes five years of salary, support. Two BioMedical Laureates will be selected each year, one in basic science, the other in translational or clinical science.
The Junior Laureate Program seeks candidates who have completed their doctoral degrees. Junior Laureates will have the opportunity to develop their own independent research program as a member of an existing research team. Upon completion of research milestones, the Junior Laureate will transition to a Mount Sinai BioMedical Laureate position and benefits package. Two Junior Laureates will be selected each year, again one in basic science, the other in translational or clinical science.
“Having experienced first-hand the barriers and challenges associated with establishing a career in science as a Black or Latina scientist, I am really delighted that Mount Sinai is putting forth this effort and investing in what is truly the future of our research workforce,” says Lynne D. Richardson, MD, Professor of Emergency Medicine and of Population Health Science and Policy, System Vice Chair of Emergency Medicine, and Co-Director of the Institute for Health Equity Research, Icahn School of Medicine at Mount Sinai.
In partnership with the Mount Sinai Office for Diversity and Inclusion and the Center for Multicultural and Community Affairs, Laureates will be mentored and guided by an advisory group of diverse leaders in science and medicine. Mentorship will form the bedrock of each program.
“Mount Sinai Laureates will be given extensive professional training and guidance as they navigate a career in academic medicine,” says Eric J. Nestler, MD, PhD, Nash Family Professor of Neuroscience, Director of The Friedman Brain Institute, and Dean for Academic and Scientific Affairs. “We will do everything we can to ensure that our Laureates thrive and their research flourishes. In five years, these programs will add 20 Black and Latinx scientists to our faculty, fundamentally changing the basic and clinical research landscape at Mount Sinai. Diversity, inclusion, and equity represent the means of achieving our mission to advance biomedicine and provide compassionate and equitable care in service to our community.”
Candidates interested in more information should please contact Eric J. Nestler, MD, PhD, at firstname.lastname@example.org.
About the Mount Sinai Health System
The Mount Sinai Health System is New York City's largest academic medical system, encompassing eight hospitals, a leading medical school, and a vast network of ambulatory practices throughout the greater New York region. Mount Sinai advances medicine and health through unrivaled education and translational research and discovery to deliver care that is the safest, highest-quality, most accessible and equitable, and the best value of any health system in the nation. The Health System includes approximately 7,300 primary and specialty care physicians; 13 joint-venture ambulatory surgery centers; more than 415 ambulatory practices throughout the five boroughs of New York City, Westchester, Long Island, and Florida; and more than 30 affiliated community health centers. The Mount Sinai Hospital is ranked on U.S. News & World Report's "Honor Roll" of the top 20 U.S. hospitals and is top in the nation by specialty: No. 1 in Geriatrics and top 20 in Cardiology/Heart Surgery, Diabetes/Endocrinology, Gastroenterology/GI Surgery, Neurology/Neurosurgery, Orthopedics, Pulmonology/Lung Surgery, Rehabilitation, and Urology. New York Eye and Ear Infirmary of Mount Sinai is ranked No. 12 in Ophthalmology. Mount Sinai Kravis Children's Hospital is ranked in U.S. News & World Report’s “Best Children’s Hospitals” among the country’s best in four out of 10 pediatric specialties. The Icahn School of Medicine is one of three medical schools that have earned distinction by multiple indicators: ranked in the top 20 by U.S. News & World Report's "Best Medical Schools," aligned with a U.S. News & World Report "Honor Roll" Hospital, and No. 14 in the nation for National Institutes of Health funding. Newsweek’s “The World’s Best Smart Hospitals” ranks The Mount Sinai Hospital as No. 1 in New York and in the top five globally, and Mount Sinai Morningside in the top 20 globally.